RLFTF
MindMaze Therapeutics Holding SA
Price Chart
Latest Quote
$0.29
| Previous Close | $0.33 |
| Open | $0.29 |
| Day High | $0.29 |
| Day Low | $0.29 |
| Volume | 25 |
Stock Information
| Shares Outstanding | 12.59M |
| Revenue | $810K |
| Net Income | $-12.50M |
| Market Cap | $3.63M |
| EPS (TTM) | $-1.70 |
| Exchange | OQB |
đ Comprehensive Analysis
Company Data
| Sales | $810K |
| Income | $-12.50M |
| Book/sh | $3.26 |
| Employees | 10 |
Financial Ratios
| Quick Ratio | 1.05 |
| Current Ratio | 1.20 |
Returns & Margins
| ROA | -25.46% |
| ROE | -51.56% |
| Gross Margin | 92.06% |
| Operating Margin | -1637.85% |
Ownership
| Insider Ownership | 55.03% |
| Institutional Ownership | 26.06% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| P/S | 5.66 |
| P/B | 0.09 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $0.47 |
| SMA50 | $0.45 |
| SMA200 | $2.02 |
| RSI | 12.06 |
| ATR | 0.0406 |
| Shares Float | 52.40M |
| Rel Volume | 3.81 |
Performance History
| Week | -29.19% |
| Month | -34.48% |
| Quarter | -42.88% |
| 6 Months | -91.33% |
| YTD | -86.54% |
| Year | -88.29% |
| 3 Years | -90.97% |
| 5 Years | -99.70% |
| 10 Years | -99.76% |
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-15 | $0.32 | 10,500 |
| 2026-06-12 | $0.38 | 0 |
| 2026-06-11 | $0.38 | 2,200 |
| 2026-06-10 | $0.39 | 5,300 |
| 2026-06-09 | $0.43 | 3,200 |
| 2026-06-08 | $0.46 | 400 |
| 2026-06-05 | $0.48 | 500 |
| 2026-06-04 | $0.47 | 1,300 |
| 2026-06-03 | $0.45 | 1,600 |
| 2026-06-02 | $0.48 | 4,400 |
| 2026-06-01 | $0.48 | 4,200 |
| 2026-05-29 | $0.48 | 2,400 |
| 2026-05-28 | $0.48 | 1,500 |
| 2026-05-27 | $0.47 | 200 |
| 2026-05-26 | $0.54 | 2,700 |
| 2026-05-22 | $0.56 | 2,300 |
| 2026-05-21 | $0.59 | 1,700 |
| 2026-05-20 | $0.53 | 3,800 |
| 2026-05-19 | $0.54 | 6,900 |
| 2026-05-18 | $0.54 | 0 |
About MindMaze Therapeutics Holding SA
MindMaze Therapeutics Holding SA operates as a commercial-stage biopharmaceutical and neurotechnology company in Asia, the United States, Switzerland, rest of Europe, and internationally. The company offers MindPod system, a supervised in-clinic neurorehabilitation system designed to initiate and intensify the recovery journey; MindMotion GO, which extends protocolized neurotherapeutics into outpatient and home settings; MindMotion Companion, an application that manages prescription, monitoring and documentation across MindMaze Therapeutics' neurotherapeutics ecosystem; and the patient app, a patient-facing mobile application, that supports clinic-to-home continuity by making prescribed therapy easy to follow outside the clinic. It also provides Izar hand therapy device which supports fine motor rehabilitation; Physilog sensor, a wearable inertial sensing device designed to quantify human movement; toaprun, a training for Parkinson's therapy-reimagined through play. The company was founded in 2012 and is headquartered in Geneva, Switzerland.
đ° Latest News
Income Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $2,575,000 | $1,736,000 | $1,250,000 | $19,774,000 |
| Cost Of Revenue | $2,575,000 | $1,736,000 | $1,250,000 | $19,774,000 |
| Total Revenue | $8,417,000 | $6,033,000 | $6,081,000 | $3,321,000 |
| Operating Revenue | $8,417,000 | $6,033,000 | $6,081,000 | $3,321,000 |
| Expenses | ||||
| Interest Expense | $215,000 | $330,000 | $1,434,000 | $797,000 |
| Total Expenses | $16,323,000 | $25,811,000 | $41,555,000 | $37,932,000 |
| Other Income Expense | $-11,371,000 | $-91,115,000 | $-16,940,000 | $362,000 |
| Other Non Operating Income Expenses | $220,000 | $64,000 | $341,000 | $19,000 |
| Net Non Operating Interest Income Expense | $-79,000 | $-791,000 | $-1,902,000 | $-1,276,000 |
| Total Other Finance Cost | $52,000 | $554,000 | $486,000 | $519,000 |
| Interest Expense Non Operating | $215,000 | $330,000 | $1,434,000 | $797,000 |
| Operating Expense | $13,748,000 | $24,075,000 | $40,305,000 | $18,158,000 |
| Selling And Marketing Expense | $588,000 | $2,200,000 | $3,307,000 | $365,000 |
| General And Administrative Expense | $9,242,000 | $17,229,000 | $20,745,000 | $15,871,000 |
| Other Operating Expenses | - | - | $1,308,000 | $-114,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-17,119,000 | $-98,181,000 | $-50,790,000 | $-34,705,000 |
| Net Interest Income | $-79,000 | $-791,000 | $-1,902,000 | $-1,276,000 |
| Interest Income | $188,000 | $93,000 | $18,000 | $40,000 |
| Normalized Income | $-6,867,588 | $-18,025,871 | $-34,630,821 | $-35,040,083 |
| Net Income From Continuing And Discontinued Operation | $-17,119,000 | $-98,181,000 | $-50,790,000 | $-34,705,000 |
| Total Operating Income As Reported | $-18,885,000 | $-110,828,000 | $-52,040,000 | $-34,306,000 |
| Net Income Common Stockholders | $-17,119,000 | $-98,181,000 | $-50,790,000 | $-34,705,000 |
| Net Income | $-17,119,000 | $-98,181,000 | $-50,790,000 | $-34,705,000 |
| Net Income Including Noncontrolling Interests | $-17,119,000 | $-98,181,000 | $-50,790,000 | $-34,705,000 |
| Net Income Continuous Operations | $-17,119,000 | $-98,181,000 | $-50,790,000 | $-34,705,000 |
| Pretax Income | $-19,356,000 | $-111,684,000 | $-54,316,000 | $-35,525,000 |
| Special Income Charges | $-11,504,000 | $-91,114,000 | $-16,907,000 | $286,000 |
| Interest Income Non Operating | $188,000 | $93,000 | $18,000 | $40,000 |
| Operating Income | $-7,906,000 | $-19,778,000 | $-35,474,000 | $-34,611,000 |
| Depreciation Amortization Depletion Income Statement | $2,561,000 | $3,318,000 | $3,860,000 | $2,036,000 |
| Depreciation And Amortization In Income Statement | $2,561,000 | $3,318,000 | $3,860,000 | $2,036,000 |
| Amortization Of Intangibles Income Statement | $1,930,000 | $2,682,000 | $3,448,000 | - |
| Depreciation Income Statement | $631,000 | $636,000 | $412,000 | $2,036,000 |
| Gross Profit | $5,842,000 | $4,297,000 | $4,831,000 | $-16,453,000 |
| Per Share | ||||
| Diluted EPS | $-1.36 | $-8.35 | $-4.80 | $-4.00 |
| Basic EPS | $-1.36 | $-8.35 | $-4.80 | $-4.00 |
| Other | ||||
| Tax Effect Of Unusual Items | $-1,339,588 | $-11,023,871 | $-1,121,821 | $7,917 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-4,989,000 | $-16,857,000 | $-31,741,000 | $-33,035,000 |
| Total Unusual Items | $-11,591,000 | $-91,179,000 | $-17,281,000 | $343,000 |
| Total Unusual Items Excluding Goodwill | $-11,591,000 | $-91,179,000 | $-17,281,000 | $343,000 |
| Reconciled Depreciation | $2,561,000 | $3,318,000 | $3,860,000 | $2,036,000 |
| EBITDA (Bullshit earnings) | $-16,580,000 | $-108,036,000 | $-49,022,000 | $-32,692,000 |
| EBIT | $-19,141,000 | $-111,354,000 | $-52,882,000 | $-34,728,000 |
| Diluted Average Shares | $12,540,439 | $11,752,466 | $10,570,281 | $8,982,673 |
| Basic Average Shares | $12,540,439 | $11,752,466 | $10,570,281 | $8,982,673 |
| Diluted NI Availto Com Stockholders | $-17,119,000 | $-98,181,000 | $-50,790,000 | $-34,705,000 |
| Tax Provision | $-2,237,000 | $-13,503,000 | $-3,526,000 | $-820,000 |
| Gain On Sale Of Ppe | $899,000 | $125,000 | $0 | - |
| Other Special Charges | $305,000 | - | $-94,000 | $-978,000 |
| Write Off | $-237,000 | $126,000 | $-625,000 | $692,000 |
| Impairment Of Capital Assets | $16,832,000 | $95,895,000 | $26,424,000 | $0 |
| Restructuring And Mergern Acquisition | $-4,497,000 | $-4,782,000 | $-8,892,000 | - |
| Gain On Sale Of Security | $-87,000 | $-65,000 | $-374,000 | $57,000 |
| Amortization | $1,930,000 | $2,682,000 | $3,448,000 | - |
| Research And Development | $1,357,000 | $1,328,000 | $12,393,000 | - |
| Selling General And Administration | $9,830,000 | $19,429,000 | $24,052,000 | $16,236,000 |
| Other Gand A | $3,262,000 | $5,391,000 | $7,747,000 | $6,750,000 |
| Salaries And Wages | $5,980,000 | $11,838,000 | $12,998,000 | $9,121,000 |
| Otherunder Preferred Stock Dividend | - | - | $0 | $0 |
| Gain On Sale Of Business | - | - | - | $0 |
Balance Sheet (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $5,639,000 | $-2,186,000 | $-17,498,000 | $-10,769,000 |
| Total Assets | $53,224,000 | $76,390,000 | $188,798,000 | $251,618,000 |
| Total Non Current Assets | $33,536,000 | $58,086,000 | $166,215,000 | $196,648,000 |
| Other Non Current Assets | $115,000 | $116,000 | $114,000 | $76,000 |
| Non Current Deferred Assets | $0 | $589,000 | $495,000 | $1,737,000 |
| Non Current Deferred Taxes Assets | $0 | $589,000 | $495,000 | $1,737,000 |
| Goodwill And Other Intangible Assets | $31,025,000 | $54,414,000 | $162,915,000 | $192,299,000 |
| Other Intangible Assets | $30,730,000 | $53,868,000 | $155,897,000 | $183,641,000 |
| Current Assets | $19,688,000 | $18,304,000 | $22,583,000 | $54,970,000 |
| Assets Held For Sale Current | $1,310,000 | $0 | - | - |
| Prepaid Assets | $227,000 | $345,000 | $864,000 | $7,072,000 |
| Inventory | $1,042,000 | $557,000 | $227,000 | $391,000 |
| Receivables | $2,029,000 | $2,846,000 | $2,255,000 | $2,746,000 |
| Other Receivables | $592,000 | $1,675,000 | $787,000 | $1,329,000 |
| Accounts Receivable | $1,437,000 | $1,171,000 | $1,321,000 | $1,302,000 |
| Allowance For Doubtful Accounts Receivable | $-222,000 | $-248,000 | $-227,000 | $-204,000 |
| Gross Accounts Receivable | $1,659,000 | $1,419,000 | $1,548,000 | $1,506,000 |
| Cash Cash Equivalents And Short Term Investments | $15,080,000 | $14,556,000 | $19,237,000 | $44,761,000 |
| Cash And Cash Equivalents | $15,080,000 | $14,556,000 | $19,237,000 | $44,761,000 |
| Taxes Receivable | - | $168,000 | $147,000 | $115,000 |
| Cash Financial | - | - | $19,237,000 | $44,761,000 |
| Non Current Note Receivables | - | - | - | $0 |
| Restricted Cash | - | - | - | $0 |
| Debt | ||||
| Total Debt | $2,143,000 | $2,956,000 | $3,064,000 | $3,014,000 |
| Long Term Debt And Capital Lease Obligation | $1,663,000 | $2,086,000 | $2,248,000 | $2,588,000 |
| Current Debt And Capital Lease Obligation | $480,000 | $870,000 | $816,000 | $426,000 |
| Long Term Debt | - | $9,000 | $16,000 | $396,000 |
| Current Debt | - | $346,000 | $372,000 | $95,000 |
| Other Current Borrowings | - | $346,000 | $372,000 | $95,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $16,560,000 | $24,162,000 | $43,381,000 | $70,088,000 |
| Total Non Current Liabilities Net Minority Interest | $11,578,000 | $17,244,000 | $32,665,000 | $50,355,000 |
| Non Current Deferred Liabilities | $6,532,000 | $7,366,000 | $20,736,000 | $25,504,000 |
| Non Current Deferred Taxes Liabilities | $4,540,000 | $7,366,000 | $20,736,000 | $25,504,000 |
| Current Liabilities | $4,982,000 | $6,918,000 | $10,716,000 | $19,733,000 |
| Other Current Liabilities | $57,000 | $452,000 | $143,000 | $72,000 |
| Current Deferred Liabilities | $852,000 | $196,000 | $776,000 | $0 |
| Payables And Accrued Expenses | $3,593,000 | $5,165,000 | $5,887,000 | $7,152,000 |
| Payables | $1,627,000 | $2,380,000 | $3,252,000 | $5,009,000 |
| Accounts Payable | $1,627,000 | $1,025,000 | $1,625,000 | $1,700,000 |
| Total Tax Payable | - | $1,100,000 | $347,000 | $2,059,000 |
| Other Payable | - | - | $1,280,000 | $1,250,000 |
| Equity | ||||
| Common Stock Equity | $36,664,000 | $52,228,000 | $145,417,000 | $181,530,000 |
| Total Equity Gross Minority Interest | $36,664,000 | $52,228,000 | $145,417,000 | $181,530,000 |
| Stockholders Equity | $36,664,000 | $52,228,000 | $145,417,000 | $181,530,000 |
| Other Equity Interest | $5,637,000 | $5,371,000 | $4,557,000 | $2,371,000 |
| Gains Losses Not Affecting Retained Earnings | $756,000 | $779,000 | $716,000 | $255,000 |
| Retained Earnings | $-235,744,000 | $-218,264,000 | $-119,599,000 | $-69,751,000 |
| Other | ||||
| Treasury Shares Number | $1,500,398 | $1,500,398 | $3,027,023 | $749,668 |
| Ordinary Shares Number | $12,540,439 | $12,540,439 | $11,013,812 | $10,283,668 |
| Share Issued | $14,040,837 | $14,040,837 | $11,013,812 | $10,283,668 |
| Tangible Book Value | $5,639,000 | $-2,186,000 | $-17,498,000 | $-10,769,000 |
| Invested Capital | $36,664,000 | $52,574,000 | $145,805,000 | $182,021,000 |
| Working Capital | $14,706,000 | $11,386,000 | $11,867,000 | $35,237,000 |
| Capital Lease Obligations | $2,143,000 | $2,610,000 | $2,676,000 | $2,523,000 |
| Total Capitalization | $36,664,000 | $52,228,000 | $145,433,000 | $181,926,000 |
| Foreign Currency Translation Adjustments | $756,000 | $779,000 | $716,000 | $255,000 |
| Treasury Stock | $150,000 | $6,001,000 | $12,108,000 | $2,999,000 |
| Additional Paid In Capital | $264,761,000 | $214,180,000 | $215,688,000 | $207,521,000 |
| Capital Stock | $1,404,000 | $56,163,000 | $56,163,000 | $44,133,000 |
| Common Stock | $1,404,000 | $56,163,000 | $56,163,000 | $44,133,000 |
| Employee Benefits | $1,396,000 | $1,589,000 | $1,772,000 | $2,793,000 |
| Non Current Pension And Other Postretirement Benefit Plans | $1,396,000 | $1,589,000 | $1,772,000 | $2,793,000 |
| Non Current Deferred Revenue | $1,992,000 | $0 | - | - |
| Long Term Capital Lease Obligation | $1,663,000 | $2,086,000 | $2,232,000 | $2,192,000 |
| Long Term Provisions | $1,987,000 | $6,203,000 | $7,909,000 | $19,470,000 |
| Current Deferred Revenue | $852,000 | $196,000 | $776,000 | $0 |
| Current Capital Lease Obligation | $480,000 | $524,000 | $444,000 | $331,000 |
| Current Accrued Expenses | $1,966,000 | $2,785,000 | $2,635,000 | $2,143,000 |
| Dueto Related Parties Current | $0 | $1,355,000 | $1,280,000 | $1,250,000 |
| Goodwill | $295,000 | $546,000 | $7,018,000 | $8,658,000 |
| Net PPE | $2,396,000 | $2,967,000 | $2,691,000 | $2,536,000 |
| Accumulated Depreciation | $-1,463,000 | $-1,056,000 | $-573,000 | $-179,000 |
| Gross PPE | $3,859,000 | $4,023,000 | $3,264,000 | $2,715,000 |
| Other Properties | $1,427,000 | $1,503,000 | $735,000 | $177,000 |
| Buildings And Improvements | $2,432,000 | $2,520,000 | $2,529,000 | $2,538,000 |
| Properties | $0 | $0 | $0 | $0 |
| Inventories Adjustments Allowances | $0 | $-2,827,000 | $-2,670,000 | $-2,717,000 |
| Finished Goods | $862,000 | $656,000 | $139,000 | $366,000 |
| Raw Materials | $180,000 | $2,728,000 | $2,758,000 | $2,742,000 |
| Current Provisions | - | $235,000 | $3,094,000 | $12,083,000 |
| Line Of Credit | - | - | - | $67,000 |
| Other Short Term Investments | - | - | - | $0 |
Cash Flow Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-3,088,000 | $-18,058,000 | $-24,647,000 | $-49,426,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-2,916,000 | $-17,612,000 | $-24,126,000 | $-35,718,000 |
| Cash Flow From Continuing Operating Activities | $-2,916,000 | $-17,612,000 | $-24,126,000 | $-35,718,000 |
| Operating Gains Losses | $-1,453,000 | $-792,000 | $-79,000 | $433,000 |
| Investing Activities | ||||
| Capital Expenditure | $-172,000 | $-446,000 | $-521,000 | $-13,708,000 |
| Investing Cash Flow | $4,401,000 | $8,695,000 | $-7,999,000 | $-30,262,000 |
| Cash Flow From Continuing Investing Activities | $4,401,000 | $8,695,000 | $-7,999,000 | $-30,262,000 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $0 | $5,094,000 | $7,111,000 | $76,088,000 |
| Financing Cash Flow | $-862,000 | $4,050,000 | $6,417,000 | $67,689,000 |
| Cash Flow From Continuing Financing Activities | $-862,000 | $4,050,000 | $6,417,000 | $67,689,000 |
| Net Common Stock Issuance | $0 | $5,094,000 | $7,111,000 | $76,088,000 |
| Common Stock Issuance | $0 | $5,094,000 | $7,111,000 | $76,088,000 |
| Net Other Financing Charges | - | $-494,000 | $-223,000 | $-2,848,000 |
| Other | ||||
| Repayment Of Debt | $-862,000 | $-550,000 | $-471,000 | $-5,366,000 |
| End Cash Position | $15,080,000 | $14,556,000 | $19,237,000 | $44,761,000 |
| Beginning Cash Position | $14,556,000 | $19,237,000 | $44,761,000 | $43,154,000 |
| Effect Of Exchange Rate Changes | $-99,000 | $186,000 | $184,000 | $-102,000 |
| Changes In Cash | $623,000 | $-4,867,000 | $-25,708,000 | $1,709,000 |
| Net Issuance Payments Of Debt | $-862,000 | $-550,000 | $-471,000 | $-5,366,000 |
| Net Long Term Debt Issuance | $-862,000 | $-550,000 | $-471,000 | $-5,366,000 |
| Long Term Debt Payments | $-862,000 | $-550,000 | $-471,000 | $-5,366,000 |
| Interest Received Cfi | $188,000 | $93,000 | $18,000 | $7,000 |
| Net Investment Purchase And Sale | $2,000 | $-5,000 | $424,000 | $109,000 |
| Sale Of Investment | $2,000 | $0 | $462,000 | $132,000 |
| Purchase Of Investment | $0 | $-5,000 | $-38,000 | $-23,000 |
| Net Intangibles Purchase And Sale | $4,216,000 | $9,053,000 | $-488,000 | $-13,708,000 |
| Sale Of Intangibles | $4,374,000 | $9,053,000 | $0 | - |
| Purchase Of Intangibles | $-158,000 | $0 | $-488,000 | $-13,708,000 |
| Net PPE Purchase And Sale | $-5,000 | $-446,000 | $-33,000 | $11,000 |
| Sale Of PPE | $9,000 | $0 | $0 | $11,000 |
| Purchase Of PPE | $-14,000 | $-446,000 | $-33,000 | $0 |
| Change In Working Capital | $2,679,000 | $-991,000 | $5,592,000 | $-5,234,000 |
| Change In Other Working Capital | $2,391,000 | $440,000 | $-586,000 | $100,000 |
| Change In Other Current Assets | $1,437,000 | $-163,000 | $6,481,000 | $-2,585,000 |
| Change In Payables And Accrued Expense | $-424,000 | $-1,067,000 | $-448,000 | $-2,430,000 |
| Change In Payable | $-424,000 | $-1,067,000 | $-448,000 | $-2,430,000 |
| Change In Account Payable | $602,000 | $-599,000 | $-75,000 | $-823,000 |
| Change In Inventory | $-485,000 | $-330,000 | $164,000 | $-111,000 |
| Change In Receivables | $-240,000 | $129,000 | $-19,000 | $-208,000 |
| Changes In Account Receivables | $-240,000 | $129,000 | $-19,000 | $-208,000 |
| Other Non Cash Items | $-4,182,000 | $-4,135,000 | $-6,990,000 | $1,219,000 |
| Stock Based Compensation | $266,000 | $814,000 | $2,186,000 | $1,143,000 |
| Asset Impairment Charge | $16,569,000 | $95,858,000 | $25,995,000 | $470,000 |
| Deferred Tax | $-2,237,000 | $-13,503,000 | $-3,526,000 | $-820,000 |
| Deferred Income Tax | $-2,237,000 | $-13,503,000 | $-3,526,000 | $-820,000 |
| Depreciation Amortization Depletion | $2,561,000 | $3,318,000 | $3,860,000 | $2,036,000 |
| Depreciation And Amortization | $2,561,000 | $3,318,000 | $3,860,000 | $2,036,000 |
| Amortization Cash Flow | $1,930,000 | $2,682,000 | $3,448,000 | - |
| Amortization Of Intangibles | $1,930,000 | $2,682,000 | $3,448,000 | - |
| Depreciation | $631,000 | $636,000 | $412,000 | $2,036,000 |
| Pension And Employee Benefit Expense | $-554,000 | $-667,000 | $-79,000 | $1,266,000 |
| Gain Loss On Sale Of PPE | $-899,000 | $-125,000 | $0 | $3,000 |
| Net Income From Continuing Operations | $-17,119,000 | $-98,181,000 | $-50,790,000 | $-34,705,000 |
| Net Business Purchase And Sale | - | $0 | $-7,920,000 | $-16,681,000 |
| Purchase Of Business | - | $0 | $-7,920,000 | $-16,681,000 |
| Interest Paid Cfo | - | $-143,000 | $-374,000 | $-260,000 |
| Issuance Of Debt | - | - | - | $0 |
| Long Term Debt Issuance | - | - | - | $0 |
| Change In Other Current Liabilities | - | - | - | $0 |
| Gain Loss On Investment Securities | - | - | - | $54,000 |
| Gain Loss On Sale Of Business | - | - | - | $0 |